Skip to main content
. 2017 Mar 16;15:56. doi: 10.1186/s12916-017-0810-z

Fig. 7.

Fig. 7

Metabolic network analysis enables pancreatic adenocarcinoma (PA) prognostication. Long-term survival-related samples (n = 8) were compared to short-term survival samples (n = 9) according to ADEMA results. No neoadjuvant chemotherapy was used. The red, green, and blue arrows, respectively, indicate the metabolites that are predicted to increase, decrease, or remain stable in long-term survivors